SpineGuard Reports 29 Percent Growth in Second Quarter

SpineGuard, a developer of disposable medical devices is reporting a 29 percent increase in Q2 revenue, to 1.9 million euros.
 
“Our second quarter sales performance is very satisfactory, in line with management’s expectations,” said Pierre Jérôme, co-founder and CEO of SpineGuard. “The PediGuard Threaded, launched in May at the international congress ‘SpineWeek’ and approved in the U.S. mid-June, is beginning to contribute to our strong revenue growth. It confirms the excellent feedback received from the surgeons involved in its limited release earlier this year.”
 
Data released by SpineGuard show that first-quarter revenue rose 16 percent to 1.76 million euros, and half-year sales jumped 22 percent to 3.63 million euros. 

Global revenue in the second quarter of 2016 increased 29 percent on a reported basis and 31 percent at constant exchange rate. In the first half of 2016 4,351 PediGuard units were sold compared with 3,716 in the first half of 2015, including 2,449 (56 percent) in the United States, where revenue grew 26 percent (same at constant exchange) to 2.86 million euros in the first half of 2016 compared with 2.27 million euros in the same period last year.
 
Co-founded in 2009 in France and the United States by Jérôme and Stéphane Bette, SpineGuard’s mission is to make spine surgery safer by bringing real-time digital technology into the operating room. Its primary objective is to establish its proprietary DSG (Dynamic Surgical Guidance) technology as the global standard of surgical care, starting with safer screw placement in spine surgery and then in other surgeries.
 
PediGuard, the first device designed using DSG, was co-invented by Maurice Bourlion, Ph.D., Ciaran Bolger, M.D., Ph.D., and Alain Vanquaethem, a biomedical engineer. It is touted as the world’s first and only handheld device capable of alerting surgeons to potential pedicular or vertebral breaches. More than 45,000 surgical procedures have been performed worldwide with PediGuard. Numerous studies published in peer-reviewed medical and scientific journals have demonstrated the multiple benefits that PediGuard delivers to patients, surgical staff and hospitals.
In 2015, SpineGuard started to expand the applications of DSG into pedicle screws through partnerships with innovative surgical companies in France and the United States. SpineGuard has offices in San Francisco, Calif., and Paris, France.